Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18210999rdf:typepubmed:Citationlld:pubmed
pubmed-article:18210999lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:18210999lifeskim:mentionsumls-concept:C0037659lld:lifeskim
pubmed-article:18210999lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:18210999lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:18210999lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:18210999lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:18210999pubmed:issue3lld:pubmed
pubmed-article:18210999pubmed:dateCreated2008-2-8lld:pubmed
pubmed-article:18210999pubmed:abstractTextWe describe synthesis, conformational studies, and binding to the five somatostatin receptors (sst 1-5) of a few analogues of the cyclic octapeptide octreotide (1), where the disulfide bridge was replaced by a dicarba group. These analogues were prepared by on-resin RCM of linear hepta-peptides containing two allylglycine residues; first- and second-generation Grubbs catalyst efficiencies were compared. The C=C bridge was hydrogenated via two different methods. Binding experiments showed that two analogues had good affinity and high selectivity for the sst5 receptor. Three-dimensional structures of the active analogues were determined by (1)H NMR spectroscopy. Conformation-affinity relationships confirmed the importance of D-Phe(2) orientation for sst2 affinity. Moreover, helical propensities well correlates with the peptide sst5 affinity. The presence of the bulky aromatic side chain of Tyr(Bzl)(10) favored the formation of a 3(10)-helix and enhanced the sst5 selectivity suppressing the sst2 affinity. Finally, a new pharmacophore model for the sst5 was developed.lld:pubmed
pubmed-article:18210999pubmed:languageenglld:pubmed
pubmed-article:18210999pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18210999pubmed:citationSubsetIMlld:pubmed
pubmed-article:18210999pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18210999pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18210999pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18210999pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18210999pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18210999pubmed:statusMEDLINElld:pubmed
pubmed-article:18210999pubmed:monthFeblld:pubmed
pubmed-article:18210999pubmed:issn0022-2623lld:pubmed
pubmed-article:18210999pubmed:authorpubmed-author:ReubiJean...lld:pubmed
pubmed-article:18210999pubmed:authorpubmed-author:CarotenutoAlf...lld:pubmed
pubmed-article:18210999pubmed:authorpubmed-author:NovellinoEtto...lld:pubmed
pubmed-article:18210999pubmed:authorpubmed-author:PapiniAnna...lld:pubmed
pubmed-article:18210999pubmed:authorpubmed-author:GinanneschiMa...lld:pubmed
pubmed-article:18210999pubmed:authorpubmed-author:GoriFrancesca...lld:pubmed
pubmed-article:18210999pubmed:authorpubmed-author:PiccandVéroni...lld:pubmed
pubmed-article:18210999pubmed:authorpubmed-author:D'AddonaDebor...lld:pubmed
pubmed-article:18210999pubmed:authorpubmed-author:Di...lld:pubmed
pubmed-article:18210999pubmed:issnTypePrintlld:pubmed
pubmed-article:18210999pubmed:day14lld:pubmed
pubmed-article:18210999pubmed:volume51lld:pubmed
pubmed-article:18210999pubmed:ownerNLMlld:pubmed
pubmed-article:18210999pubmed:authorsCompleteYlld:pubmed
pubmed-article:18210999pubmed:pagination512-20lld:pubmed
pubmed-article:18210999pubmed:meshHeadingpubmed-meshheading:18210999...lld:pubmed
pubmed-article:18210999pubmed:meshHeadingpubmed-meshheading:18210999...lld:pubmed
pubmed-article:18210999pubmed:meshHeadingpubmed-meshheading:18210999...lld:pubmed
pubmed-article:18210999pubmed:meshHeadingpubmed-meshheading:18210999...lld:pubmed
pubmed-article:18210999pubmed:meshHeadingpubmed-meshheading:18210999...lld:pubmed
pubmed-article:18210999pubmed:meshHeadingpubmed-meshheading:18210999...lld:pubmed
pubmed-article:18210999pubmed:meshHeadingpubmed-meshheading:18210999...lld:pubmed
pubmed-article:18210999pubmed:meshHeadingpubmed-meshheading:18210999...lld:pubmed
pubmed-article:18210999pubmed:meshHeadingpubmed-meshheading:18210999...lld:pubmed
pubmed-article:18210999pubmed:meshHeadingpubmed-meshheading:18210999...lld:pubmed
pubmed-article:18210999pubmed:meshHeadingpubmed-meshheading:18210999...lld:pubmed
pubmed-article:18210999pubmed:meshHeadingpubmed-meshheading:18210999...lld:pubmed
pubmed-article:18210999pubmed:meshHeadingpubmed-meshheading:18210999...lld:pubmed
pubmed-article:18210999pubmed:meshHeadingpubmed-meshheading:18210999...lld:pubmed
pubmed-article:18210999pubmed:meshHeadingpubmed-meshheading:18210999...lld:pubmed
pubmed-article:18210999pubmed:meshHeadingpubmed-meshheading:18210999...lld:pubmed
pubmed-article:18210999pubmed:year2008lld:pubmed
pubmed-article:18210999pubmed:articleTitleNovel sst5-selective somatostatin dicarba-analogues: synthesis and conformation-affinity relationships.lld:pubmed
pubmed-article:18210999pubmed:affiliationLaboratory of Peptides and Proteins, Chemistry and Biology, Department of Organic Chemistry, University of Firenze, Via Lastruccia 13 I-50019, Sesto Fiorentino, Italy.lld:pubmed
pubmed-article:18210999pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18210999pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:18210999lld:chembl